Coronary artery bypass graft surgery up-regulates genes involved in platelet aggregation

S-J Reilly1, N Li, J Liska

  • 1Department of Medicine, Atherosclerosis Research Unit, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.

Insights

Coronary artery bypass graft surgery increases platelet aggregation. Key proteins like glycoprotein (GP)IIb/IIIa show elevated mRNA and expression post-surgery, potentially increasing thrombus formation risk.

Area of Science:

  • Cardiovascular Surgery
  • Thrombosis Research
  • Platelet Biology

Background:

  • Coronary artery bypass graft (CABG) surgery can lead to increased thromboembolic events.
  • The hypercoaguable state post-CABG is linked to platelet activation and regeneration.
  • Platelets play a crucial role in thrombosis, especially after inflammatory stimuli like CABG.

Purpose of the Study:

  • To investigate changes in platelet messenger RNA (mRNA) profiles after CABG.
  • To test the hypothesis that platelets are in a prothrombotic state following CABG surgery.
  • To identify specific genes and proteins involved in post-CABG platelet activity.

Main Methods:

  • Blood samples collected from 11 patients before and after CABG (3-6 days).
  • Platelets were purified for gene expression profiling using low-density arrays (LDA).
  • Seven patients underwent gene expression profiling; four additional patients had flow cytometry for GPIIb/IIIa receptor analysis.

Main Results:

  • Significant up-regulation of glycoprotein (GP)IIb, GPIIIa, and cyclooxygenase-1 (COX-1) mRNA was observed.
  • Findings confirmed in additional patients, including flow cytometry analysis of the GPIIb/IIIa receptor.
  • Elevated GPIIb/IIIa mRNA levels correlated with increased GPIIb/IIIa expression on platelets post-CABG.

Conclusions:

  • CABG surgery increases mRNA and protein levels of key platelet aggregation factors.
  • Marked elevation of GPIIb/IIIa mRNA leads to significantly increased GPIIb/IIIa expression post-CABG.
  • Increased GPIIb/IIIa expression may contribute to heightened thrombus formation and myocardial infarction risk after CABG.
Abstract

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...